Li-FT Power Details Intersections At Echo Pegmatite Within Yellowknife Lithium Project-February 2024-www.financetom.com

Li-FT Power Details Intersections At Echo Pegmatite Within Yellowknife Lithium Project

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Li-FT Power Details Intersections At Echo Pegmatite Within Yellowknife Lithium Project

Mar 13, 2024 6:26 AM

08:46 AM EDT, 03/13/2024 (MT Newswires) -- Li-FT Power Ltd. ( LIFFF ) reported Wednesday assays from eight drill holes mainly at the Echo pegmatite within the Yellowknife lithium project in the Northwest Territories.

Results include 16 meters at 1.26% lithium oxide, 14 meters at 1.20% lithium oxide and 10 meters at 0.95% lithium oxide.

"The Echo pegmatite is living up to initial expectations," CEO Francis MacDonald said.

"We are seeing a complex stacked set of spodumene pegmatites that are shallow-dipping which is very favorable for open pit mining."

Previous page： What's Going On With MMTec Stock Thursday? Next page： Keros Therapeutics Prospects Still Strong Despite Cibotercept Hurdles, Wedbush Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With MMTec Stock Thursday?

Dec 12, 2024

MMTec, Inc. ( MTC ) shares are trading lower on Thursday after the company announced a 1-for-8 reverse stock split. The Details: The reverse stock split, approved by the board of directors on Nov. 21, 2024, will take effect on Dec. 18 at market open. It will reduce the authorized number of shares of the company’s common stock from 5,000,000,000...

Keros Therapeutics Prospects Still Strong Despite Cibotercept Hurdles, Wedbush Says

Dec 12, 2024

01:24 PM EST, 12/12/2024 (MT Newswires) -- Keros Therapeutics' ( KROS ) efforts to develop new treatments for pulmonary arterial hypertension remain potentially viable despite the company announcing Thursday that it voluntarily halted dosing in the 3 mg/kg and 4.5 mg/kg arms of its phase 2 trial for cibotercept, analysts at Wedbush wrote in a research note Thursday. The company's...

--Apple Nears Switch to In-House Chips for iPhones From Broadcom, Bloomberg Reports

Dec 12, 2024

01:21 PM EST, 12/12/2024 (MT Newswires) -- Price: 248.60, Change: +2.10, Percent Change: +0.85 ...

Market Chatter: Apple Nears Switch to In-House Chips From Broadcom

Dec 12, 2024

01:24 PM EST, 12/12/2024 (MT Newswires) -- Apple ( AAPL ) is planning to switch to a homegrown chip for Bluetooth and Wi-Fi connections for its devices next year, a move that will replace some parts provided by Broadcom ( AVGO ) , Bloomberg reported Thursday, citing people familiar with the matter. Like Apple's ( AAPL ) other in-house chips,...